Lorenol Labs announces relaunch with refined skincare and new product innovations, with a strong push into education and medical partnerships.
— Lorenol Labs, a science-driven skincare company, has announced its official relaunch following a period of internal restructuring, marking renewed growth and clinical alignment within the medical aesthetics industry.
With more than 40 years of experience working alongside dermatologists, plastic surgeons, and early laser innovators, founder Laura Montry has repositioned the company with a sharper focus on performance-led formulations and professional partnerships. In Montry’s words, the relaunch reflects a structural reset. She says, “We’ve rebuilt this company with intention. Every formulation has been revisited, and the focus now is on delivering results that professionals can stand behind.”
The company’s foundation remains rooted in solving a persistent gap Montry has witnessed in the industry. “As aesthetic procedures have advanced, post-procedure care has struggled to keep pace,” she says, observing this firsthand throughout her career. In her experience, many products used after treatments were designed to sit on the surface instead of interacting with the skin. “If a product can’t penetrate the skin, it can’t meaningfully support recovery,” she posits.
With a commitment to efficacy, Lorenol Labs formulations are built around the Dalton 500 principle to ensure that all active ingredients remain below the molecular threshold required for dermal penetration. Montry further highlights that each product is oil-based, designed to align with the skin’s natural lipid structure and support deeper absorption.
Another defining component across the product line is sulforaphane, a compound derived from broccoli seed extract. Integrated into every formulation, it is designed to support the skin’s natural enzyme activity and help regulate post-procedure inflammation at a cellular level. “Sulforaphane allows us to work within the skin; it supports recovery in a way that other regular formulations may not have the capacity to,” Montry explains.
Lorenol Labs’ relaunch places particular emphasis on two flagship products: the Dermal Night Repair and the Daily Regenerating Serum. According to Montry, both have undergone formulation enhancements to improve performance and consistency.
The Dermal Night Repair features a 2.5% retinol concentration, formulated to offer a higher potency while remaining well-tolerated due to its molecular structure. “We’re delivering a level of strength that typically causes irritation, but without the redness or peeling people expect,” she says.
The Daily Regenerating Serum complements this with a stabilized, oil-based form of vitamin C at a clinically effective concentration, designed to maintain potency while supporting collagen production. Montry adds, “We formulate at levels that actually perform, not just levels that look good on a label.”
Alongside its core products, Lorenol Labs is introducing a series of innovations developed over the past year, including a Firm Neck Cream, Daily Eye Cream, Brightening Boost Serum, and a dual plumping system featuring a hyaluronic mask and topical filler alternative. These additions expand the brand’s offering across daily skincare and post-procedure recovery, with each product designed to integrate into effective routines.
“Every product has a purpose, and every system is built to make skincare more effective and more intuitive,” Montry says.
Education remains a central pillar of the company’s strategy moving forward. “People need to understand what they’re using and why it works; that’s what builds trust and consistency in results,” she says. To facilitate that, Lorenol Labs currently supports several wholesale accounts across dermatology clinics, plastic surgery practices, and medical spas, providing in-person and virtual training. Plans are also underway to introduce live educational seminars, reinforcing the brand’s emphasis on informed usage.
As part of its expansion, Lorenol Labs will participate in the Global Aesthetics Conference in Miami, taking place from November 5th to 8th, connecting with industry professionals and further strengthening its clinical presence.
The relaunch represents a new chapter for the company, shaped by refined operations and an expanded product pipeline. Through each new formulation, Montry’s objective remains focused. She remarks, “We’re stepping forward with clarity and confidence, delivering products that truly perform and support better outcomes at every stage of the treatment process. It’s about unlocking a new frontier in recovery care.”
Contact Info:
Name: Laura Montry
Email: Send Email
Organization: Lorenol Labs
Website: https://www.lorenollabs.com/
Release ID: 89199640
If you detect any issues, problems, or errors in this press release content, kindly contact error@releasecontact.com to notify us (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). We will respond and rectify the situation in the next 8 hours.